Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadpill crossover pilot study in untreated hypertension
ACTRN12614001057673Phase 4Completed
- Sponsor
- The George Institute for Global Health
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of irbesartan, amlodipine, atenolol and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by The George Institute for Global Health. Primary endpoint: Systolic blood pressure. Started Sep 2014; status: completed.
02
Drugs
irbesartanamlodipineatenololhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ACTRN12614001057673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001057673.